Canine Parvovirus Market
Canine Parvovirus Market By Drug class (Antibiotics, Antiemetics, Intravenous (IV) Fluids), By Route of administration (Intravenous, Oral), By Distribution channel type (Hospital Pharmacies, Online Pet Drugs Stores, Veterinary Drugs Stores) - Global Review 2020 to 2030
Canine parvovirus is a contagious virus affecting dog population. The affected dogs suffer from gastrointestinal infections due parvovirus. It is a highly infectious diseases caused by either direct or indirect contact with infected fecal matter of other infected dogs.
The major symptoms include vomiting, bloody diarrhea, lethargy together with fever. The gestation period for the symptoms to occur range from three to seven days. Dehydration caused due to vomiting and diarrhea can make cases critical as this destroys the electrolyte balance of the body and makes the immune system weak. Puppies suffering from canine parvovirus are more prone to succumbing to the virus. The condition is preventable with vaccines however the mortality is above 90% in cases of untreated dogs. The virus is said to affect other mammals also like foxes and cats.
The extended periods of lockdowns and restriction on movements due to COVID-19 pandemic can affect the accessibility of veterinary hospitalization which is required in canine parvovirus infection cases. This could delay the diagnosis and treatment of the canine parvovirus condition thereby impacting the global canine parvovirus treatment market.
Canine Parvovirus Market: Drivers and Restraints
The major driver for the global canine parvovirus market would the growing pet owners worldwide which is evident from the fact that the number of pet owners has more than tripled in the USA from 1970s. The increasing income disposability of people coupled with their willingness to invest in pet care can be yet another driver for the global canine parvovirus market. The shift in the way pets are cared for and growing number of millennial pet owners can also provide push to the global canine parvovirus market. The major barrier in the development of the global canine parvovirus market could be the general unawareness among the pet owners about the canine parvovirus in the developing countries.
Canine Parvovirus Market: Overview
The global canine parvovirus market can be expected to grow at a steady rate as it is estimated that there are over 470 million pet dogs worldwide. Based on the drug class, intravenous fluids can be expected to grow robustly in the global canine parvovirus market as dehydration due to vomiting and diarrhea is a major critical condition in a dog suffering from parvovirus.
Based on route of administration, intravenous segment is poised to be the lucrative in the global canine parvovirus treatment market owing to drug administration convenience. Based on the distribution channel, the hospital pharmacies can be estimated to register a robust growth in the global canine parvovirus treatment market owing to the fact that dogs suffering from canine parvovirus in most cases need hospitalization.
Canine Parvovirus Market: Region-wise
North America is expected to constitute the major share in the global canine parvovirus treatment market since it is estimated that the households in the USA spend around 50 billion USD annually on pet care. Europe can be the next attractive market since it has a pet dog population of around 75 million. Asia can be expected as the emerging market in the global canine parvovirus treatment market since there are many countries like China, India and Japan with growing pet dog population. Middle East along with Africa can be estimated to register sluggish growth in the global canine parvovirus treatment market due to low income disposability and adoption in the region.
Avail customized purchase options for your needs
Canine Parvovirus Market: Key Players
The major players operating in the global canine parvovirus market are Merck Animal Health, Zoetis United States, Amber Naturalz, Merial (Sanofi), MSD Animal Health, Durvet, Elanco among others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
An Adaptive Approach to Modern-day Research Needs
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Europe (Germany, U.K, France, Italy, Spain)
- South Asia (India, ASEAN Countries)
- East Asia (Japan, China & South Korea)
- Oceania (Australia & New Zealand)
- Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Interested to Procure The Data
Canine Parvovirus Market: Segmentation
The global canine parvovirus market is segmented based on the drug class, route of administration, distribution channel and region.
By drug class, the global canine parvovirus treatment market is segmented as:
- Intravenous (IV) Fluids
By route of administration, the global canine parvovirus treatment market is segmented as:
By distribution channel type, the global canine parvovirus market is segmented as:
- Hospital Pharmacies
- Online Pet Drugs Stores
- Veterinary Drugs Stores
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
Respiratory Syncytial Virus (RSV) Diagnostics Market to register a 9% CAGR during the years, 2021-20...
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.